{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:01:01Z","timestamp":1786132861084,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1681\/asn.2014050508","type":"journal-article","created":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T04:26:57Z","timestamp":1412137617000},"page":"1402-1413","source":"Crossref","is-referenced-by-count":71,"title":["Renal Glycosphingolipid Metabolism Is Dysfunctional in Lupus Nephritis"],"prefix":"10.1681","volume":"26","author":[{"given":"Tamara K.","family":"Nowling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Mather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirumagal","family":"Thiyagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Hern\u00e1ndez-Corbacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Ellen","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley J.","family":"Snider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim C.","family":"Oates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah J.","family":"Siskind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20230208","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1750-1172-1-6","article-title":"Systemic lupus erythematosus.","volume":"1","author":"Manson","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"R2-19-20230208","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7861\/clinmedicine.11-3-268","article-title":"Acute systemic lupus erythematosus on the acute medical take: Are we missing anything?","volume":"11","author":"Perry","year":"2011","journal-title":"Clin Med"},{"key":"R3-19-20230208","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1016\/j.jaci.2009.10.067","article-title":"Immunologic rheumatic disorders.","volume":"125","author":"Joseph","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R4-19-20230208","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molmed.2009.12.005","article-title":"Pathogenesis of human systemic lupus erythematosus: Recent advances.","volume":"16","author":"Crisp\u00edn","year":"2010","journal-title":"Trends Mol Med"},{"key":"R5-19-20230208","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/gene.2009.39","article-title":"Recent insights into the genetic basis of systemic lupus erythematosus.","volume":"10","author":"Moser","year":"2009","journal-title":"Genes Immun"},{"key":"R6-19-20230208","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00002281-200009000-00001","article-title":"Immune cell signaling in lupus.","volume":"12","author":"Tsokos","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"R7-19-20230208","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1017\/S1462399408000562","article-title":"Targeting of the immune system in systemic lupus erythematosus.","volume":"10","author":"Ramanujam","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"R8-19-20230208","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/MCG.0b013e31820f81b8","article-title":"Gastrointestinal and hepatic manifestations of systemic lupus erythematosus.","volume":"45","author":"Ebert","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R9-19-20230208","first-page":"907","article-title":"Glomerulonephritis\u2014management in general practice.","volume":"34","author":"Isbel","year":"2005","journal-title":"Aust Fam Physician"},{"key":"R10-19-20230208","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1084\/jem.148.5.1198","article-title":"Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.","volume":"148","author":"Andrews","year":"1978","journal-title":"J Exp Med"},{"key":"R11-19-20230208","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-4614-0650-1_8","article-title":"Glycosphingolipids and kidney disease.","volume":"721","author":"Mather","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"R12-19-20230208","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-5793(86)80985-1","article-title":"Evidence for sialidase hydrolyzing gangliosides GM2 and GM1 in rat liver plasma membrane.","volume":"206","author":"Miyagi","year":"1986","journal-title":"FEBS Lett"},{"key":"R13-19-20230208","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/(SICI)1099-0895(199709)13:3<163::AID-DMR189>3.0.CO;2-Z","article-title":"Gangliosides and autoimmune diabetes.","volume":"13","author":"Misasi","year":"1997","journal-title":"Diabetes Metab Rev"},{"key":"R14-19-20230208","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/978-1-4684-1200-0_30","article-title":"Gangliosides, the thyrotropin receptor, and autoimmune thyroid disease.","volume":"174","author":"Lacetti","year":"1984","journal-title":"Adv Exp Med Biol"},{"key":"R15-19-20230208","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0304-3940(76)90033-1","article-title":"Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides.","volume":"2","author":"Nagai","year":"1976","journal-title":"Neurosci Lett"},{"key":"R16-19-20230208","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/glycob\/cwn017","article-title":"Roles of complex gangliosides in the development of experimental autoimmune encephalomyelitis.","volume":"18","author":"Miyamoto","year":"2008","journal-title":"Glycobiology"},{"key":"R17-19-20230208","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ana.410300508","article-title":"Effects of gangliosides on the expression of autoimmune demyelination in the peripheral nervous system.","volume":"30","author":"Ponzin","year":"1991","journal-title":"Ann Neurol"},{"key":"R18-19-20230208","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/jnnp.57.Suppl.26","article-title":"Gangliosides and autoimmune neuropathies: Classification and clinical aspects of autoimmune neuropathies.","volume":"57","author":"Steck","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R19-19-20230208","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1471-4159.2007.04718.x","article-title":"Gangliosides as targets for autoimmune injury to the nervous system.","volume":"103","author":"Willison","year":"2007","journal-title":"J Neurochem"},{"key":"R20-19-20230208","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0065-2776(08)60342-9","article-title":"Murine models of systemic lupus erythematosus.","volume":"37","author":"Theofilopoulos","year":"1985","journal-title":"Adv Immunol"},{"key":"R21-19-20230208","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/physiolgenomics.90211.2008","article-title":"Microarray analyses of SREBP-1a and SREBP-1c target genes identify new regulatory pathways in muscle.","volume":"34","author":"Rome","year":"2008","journal-title":"Physiol Genomics"},{"key":"R22-19-20230208","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.biochi.2004.09.018","article-title":"SREBP transcription factors: Master regulators of lipid homeostasis.","volume":"86","author":"Eberl\u00e9","year":"2004","journal-title":"Biochimie"},{"key":"R23-19-20230208","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1177\/0961203310367660","article-title":"Jak\/STAT signaling is involved in the inflammatory infiltration of the kidneys in MRL\/lpr mice.","volume":"19","author":"Wang","year":"2010","journal-title":"Lupus"},{"key":"R24-19-20230208","doi-asserted-by":"crossref","first-page":"10340","DOI":"10.1073\/pnas.90.21.10340","article-title":"The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr\/lpr.","volume":"90","author":"Drappa","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R25-19-20230208","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/glycob\/cwq098","article-title":"Beta4-galactosyltransferase-5 is a lactosylceramide synthase essential for mouse extra-embryonic development.","volume":"20","author":"Nishie","year":"2010","journal-title":"Glycobiology"},{"key":"R26-19-20230208","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1681\/ASN.V1271369","article-title":"Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis.","volume":"12","author":"P\u00e9rez de Lema","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R27-19-20230208","doi-asserted-by":"crossref","first-page":"e75175","DOI":"10.1371\/journal.pone.0075175","article-title":"Reducing FLI1 levels in the MRL\/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolism.","volume":"8","author":"Richard","year":"2013","journal-title":"PLoS ONE"},{"key":"R28-19-20230208","doi-asserted-by":"crossref","first-page":"20961","DOI":"10.1074\/jbc.M300304200","article-title":"Sphingolipid storage induces accumulation of intracellular cholesterol by stimulating SREBP-1 cleavage.","volume":"278","author":"Puri","year":"2003","journal-title":"J Biol Chem"},{"key":"R29-19-20230208","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.2337\/diabetes.54.8.2328","article-title":"Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb\/db mice with type 2 diabetes.","volume":"54","author":"Wang","year":"2005","journal-title":"Diabetes"},{"key":"R30-19-20230208","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1111\/j.1523-1755.2005.00733.x","article-title":"Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease.","volume":"68","author":"Jiang","year":"2005","journal-title":"Kidney Int"},{"key":"R31-19-20230208","doi-asserted-by":"crossref","first-page":"18919","DOI":"10.1074\/jbc.M110650200","article-title":"Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus.","volume":"277","author":"Sun","year":"2002","journal-title":"J Biol Chem"},{"key":"R32-19-20230208","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/art.23153","article-title":"Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis.","volume":"58","author":"Oates","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R33-19-20230208","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R34-19-20230208","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients.","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"R35-19-20230208","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.4049\/jimmunol.173.10.6481","article-title":"Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL\/lpr mice.","volume":"173","author":"Zhang","year":"2004","journal-title":"J Immunol"},{"key":"R36-19-20230208","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4049\/jimmunol.180.2.1231","article-title":"Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL\/lpr mice.","volume":"180","author":"Atkinson","year":"2008","journal-title":"J Immunol"},{"key":"R37-19-20230208","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ymeth.2006.05.004","article-title":"Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry.","volume":"39","author":"Bielawski","year":"2006","journal-title":"Methods"},{"key":"R38-19-20230208","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/978-1-60761-322-0_22","article-title":"Comprehensive quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry.","volume":"579","author":"Bielawski","year":"2009","journal-title":"Methods Mol Biol"},{"key":"R39-19-20230208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2007.05.018","article-title":"Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes.","volume":"45","author":"Nowling","year":"2008","journal-title":"Mol Immunol"},{"key":"R40-19-20230208","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/pmic.201300434","article-title":"MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma.","volume":"14","author":"Jones","year":"2014","journal-title":"Proteomics"},{"key":"R41-19-20230208","doi-asserted-by":"crossref","first-page":"8303","DOI":"10.1021\/ac501937d","article-title":"On-tissue localization of ceramides and other sphingolipids by MALDI mass spectrometry imaging.","volume":"86","author":"Jones","year":"2014","journal-title":"Anal Chem"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201506000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:25:09Z","timestamp":1786130709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201506000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2014050508","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}